ICU blood thinner mystery: why standard doses fail kidney patients?
NCT ID NCT07384598
Summary
This study aims to understand how a common blood thinner (enoxaparin) works in critically ill patients with kidney failure, including those on dialysis. Researchers will measure blood levels of the drug in 60 ICU patients to see if current dosing guidelines are effective. The goal is to gather information that could lead to better dosing recommendations for preventing blood clots in this vulnerable group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.